• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽及相关片段的合成、构象研究与生物活性

Synthesis, conformational studies and biological activities of VIP and related fragments.

作者信息

Fournier A, Saunders J K, St-Pierre S

出版信息

Peptides. 1984 Mar-Apr;5(2):169-77. doi: 10.1016/0196-9781(84)90202-x.

DOI:10.1016/0196-9781(84)90202-x
PMID:6473150
Abstract

VIP and related fragments were prepared by the solid-phase method. The peptides were assembled on a benzhydrylamine resin and couplings of the Boc-amino acids were carried out by the symmetrical anhydride method. Cleavage was achieved by treatment with liquid HF and purification was accomplished by successive steps of cation exchange, partition and semi-preparative high pressure liquid chromatography. The biological activities were evaluated in vitro in the rabbit perfused heart and in vivo on the rat blood pressure. Structural studies were performed by high resolution (400 MHz) 1H-NMR spectroscopy and circular dichroism. The results show that among all the fragments tested, only VIP2-28 retains significant biological activity. The fragments 1-14 and 15-28, which are devoid of activity, were found to be inactive as antagonists. VIP and some of the fragments tend to adopt the helical structure, as demonstrated by spectroscopic techniques.

摘要

血管活性肠肽(VIP)及相关片段采用固相法制备。肽段在二苯甲基胺树脂上组装,Boc - 氨基酸的偶联通过对称酸酐法进行。用液态氢氟酸处理实现裂解,通过阳离子交换、分配和半制备高压液相色谱的连续步骤完成纯化。在兔离体灌注心脏中进行体外生物活性评估,并在大鼠血压上进行体内评估。通过高分辨率(400 MHz)的1H - NMR光谱和圆二色性进行结构研究。结果表明,在所有测试片段中,只有VIP2 - 28保留显著的生物活性。发现无活性的片段1 - 14和15 - 28作为拮抗剂无活性。光谱技术表明,VIP和一些片段倾向于采用螺旋结构。

相似文献

1
Synthesis, conformational studies and biological activities of VIP and related fragments.血管活性肠肽及相关片段的合成、构象研究与生物活性
Peptides. 1984 Mar-Apr;5(2):169-77. doi: 10.1016/0196-9781(84)90202-x.
2
Synthesis of vasoactive intestinal peptide (VIP) via the mixed anhydride method.通过混合酸酐法合成血管活性肠肽(VIP)。
Peptides. 1984 Mar-Apr;5(2):167-8. doi: 10.1016/0196-9781(84)90201-8.
3
Solution structure of vasoactive intestinal polypeptide (11-28)-NH2, a fragment with analgesic properties.
Pept Res. 1996 Nov-Dec;9(6):327-31.
4
Solid-phase synthesis of porcine vasoactive intestinal peptide.猪血管活性肠肽的固相合成
Int J Pept Protein Res. 1980 Jan;15(1):73-8. doi: 10.1111/j.1399-3011.1980.tb02552.x.
5
Combined solid-phase/solution synthesis of a 31-residue vasoactive intestinal peptide analog: general method for repetitive coupling of fragments without isolation and purification of intermediates.31个残基的血管活性肠肽类似物的固-液相联合合成:无需分离和纯化中间体的片段重复偶联通用方法。
J Pept Res. 1998 Aug;52(2):155-64. doi: 10.1111/j.1399-3011.1998.tb01370.x.
6
Synthesis and pharmacological properties of the N-terminal decapeptide of the vasoactive intestinal peptide (VIP).血管活性肠肽(VIP)N端十肽的合成及其药理性质
J Med Chem. 1977 Nov;20(11):1461-4. doi: 10.1021/jm00221a019.
7
Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
Mol Pharmacol. 1992 Jan;41(1):104-9.
8
Conformation of a peptide corresponding to T4 lysozyme residues 59-81 by NMR and CD spectroscopy.通过核磁共振和圆二色光谱法确定与T4溶菌酶59 - 81位残基对应的肽段的构象。
Biochemistry. 1994 Sep 20;33(37):11174-83. doi: 10.1021/bi00203a013.
9
Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction.
Biochemistry. 1988 Oct 18;27(21):8174-81. doi: 10.1021/bi00421a028.
10
The effect of VIP on guinea pig taenia coli requires the whole sequence.血管活性肠肽对豚鼠结肠带的作用需要完整序列。
Peptides. 1984 Mar-Apr;5(2):267-9. doi: 10.1016/0196-9781(84)90217-1.

引用本文的文献

1
Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.将血管活性肠肽中的活性位点定位到四个氨基酸的核心区域:神经保护药物设计。
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4143-8. doi: 10.1073/pnas.96.7.4143.
2
Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.人结肠腺癌细胞系HT-29中血管活性肠肽(VIP)受体的分子鉴定及结构要求
Biochem J. 1985 Oct 1;231(1):139-43. doi: 10.1042/bj2310139.